Edwards Lifesciences Corp (NYSE:EW)

152.62
Delayed Data
As of Jul 20
 +2.34 / +1.56%
Today’s Change
100.20
Today|||52-Week Range
155.22
+35.41%
Year-to-Date
What's in Store for AmerisourceBergen (ABC) in Q3 Earnings?
Jul 20 / Zacks.com - Paid Partner Content
Can Overall Growth Drive Align Technology (ALGN) Q2 Earnings?
Jul 17 / Zacks.com - Paid Partner Content
Can BD Medical Drive Becton, Dickinson's (BDX) Q3 Earnings?
Jul 19 / Zacks.com - Paid Partner Content
Here's Why You Should Add Edwards Lifesciences (EW) Now
Jul 13 / Zacks.com - Paid Partner Content
Can Business Services Aid athenahealth's (ATHN) Q2 Earnings?
Jul 19 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close150.28
Today’s open150.02
Day’s range150.00 - 153.34
Volume1,550,888
Average volume (3 months)1,334,022
Market cap$32.2B
Data as of 4:01pm ET, 07/20/2018

Growth & Valuation

Earnings growth (last year)+3.45%
Earnings growth (this year)+22.00%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+15.91%
P/E ratio58.7
Price/Sales7.08
Price/Book10.83

Competitors

 Today’s
change
Today’s
% change
SNNSmith & Nephew PLC+0.36+1.03%
ISRGIntuitive Surgical-4.51-0.87%
STESTERIS plc+0.65+0.58%
HRCHill-Rom Holdings In...+0.77+0.82%
Data as of 4:02pm ET, 07/20/2018

Financials

Next reporting dateJuly 27, 2018
EPS forecast (this quarter)$1.13
Annual revenue (last year)$3.4B
Annual profit (last year)$583.6M
Net profit margin16.99%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts